Furthermore, a FOXC1 and miR-335-5p network was presented in non-small-cell lung cancer (Mosharaf et al., 2022), type 2 diabetes (Rahman et al., 2020), and vascular dementia (Shu et al., 2022). This evidence concerns the gene FOXC1 and type 2 diabetes mellitus.